-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, VoLXTHSyiaZ1y5c63zHwcVAH/nufVwH2cqOG+DQ9iKPK9wcYvHPVf54GZc9i6fXD O5G6CAuUZ84FcTFdlWGPcA== 0001019056-08-000438.txt : 20080325 0001019056-08-000438.hdr.sgml : 20080325 20080325154349 ACCESSION NUMBER: 0001019056-08-000438 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20080325 DATE AS OF CHANGE: 20080325 GROUP MEMBERS: APIS CAPITAL (QP), LP GROUP MEMBERS: APIS CAPITAL ADVISORS, LLC GROUP MEMBERS: APIS CAPITAL, LP GROUP MEMBERS: APIS GLOBAL DEEP VALUE OFFSHORE, LTD GROUP MEMBERS: APIS GLOBAL DEEP VALUE, LP GROUP MEMBERS: APIS OFFSHORE CAPITAL, LTD. GROUP MEMBERS: DANIEL J. BARKER GROUP MEMBERS: STEVEN A. WERBER, JR. SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: BIOSPECIFICS TECHNOLOGIES CORP CENTRAL INDEX KEY: 0000875622 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 113054851 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-79091 FILM NUMBER: 08709374 BUSINESS ADDRESS: STREET 1: 35 WILBUR ST CITY: LYNBROOK STATE: NY ZIP: 11563 BUSINESS PHONE: 5165937000 MAIL ADDRESS: STREET 1: 35 WILBUR STREET CITY: LYNBROOK STATE: NY ZIP: 11563 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: APIS CAPITAL ADVISORS, LLC CENTRAL INDEX KEY: 0001386892 IRS NUMBER: 200692626 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 53 FOREST AVENUE STREET 2: SUITE 103 CITY: OLD GREENWICH STATE: CT ZIP: 06870 BUSINESS PHONE: 203-364-8809 MAIL ADDRESS: STREET 1: 53 FOREST AVENUE STREET 2: SUITE 103 CITY: OLD GREENWICH STATE: CT ZIP: 06870 SC 13G 1 bstc_13g.txt SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. __)* BioSpecifics Technologies Corp. ------------------------------------------------------- (Name of Issuer) Common Stock, $0.001 par value ------------------------------------------------------- (Title of Class of Securities) 090931106 -------------------------------------------- (CUSIP Number) March 17, 2008 ------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [ ] Rule 13d-1(b) [X] Rule 13d-1(c) [ ] Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Page 1 of 13 Pages CUSIP No. 090931106 1. Names of Reporting Persons I.R.S. Identification Nos. of above persons (entities only) Steven A. Werber, Jr. 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) [ ] (b) [X] 3. SEC Use Only 4. Citizenship or Place of Organization United States NUMBER OF 5. SOLE VOTING POWER 0 SHARES BENEFICIALLY 6. SHARED VOTING POWER 296,805 OWNED BY EACH REPORTING 7. SOLE DISPOSITIVE POWER 0 PERSON WITH: 8. SHARED DISPOSITIVE POWER 296,805 9. Aggregate Amount Beneficially Owned by Each Reporting Person 296,805 10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] 11. Percent of Class Represented by Amount in Row (9) 5.2% 12. Type of Reporting Person (See Instructions) IN Page 2 of 13 Pages CUSIP No. 090931106 1. Names of Reporting Persons I.R.S. Identification Nos. of above persons (entities only) Daniel J. Barker 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) [ ] (b) [X] 3. SEC Use Only 4. Citizenship or Place of Organization United States NUMBER OF 5. SOLE VOTING POWER 0 SHARES BENEFICIALLY 6. SHARED VOTING POWER 296,805 OWNED BY EACH REPORTING 7. SOLE DISPOSITIVE POWER 0 PERSON WITH: 8. SHARED DISPOSITIVE POWER 296,805 9. Aggregate Amount Beneficially Owned by Each Reporting Person 296,805 10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] 11. Percent of Class Represented by Amount in Row (9) 5.2% 12. Type of Reporting Person (See Instructions) IN Page 3 of 13 Pages CUSIP No. 090931106 1. Names of Reporting Persons I.R.S. Identification Nos. of above persons (entities only) Apis Capital Advisors, LLC 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) [ ] (b) [X] 3. SEC Use Only 4. Citizenship or Place of Organization Delaware NUMBER OF 5. SOLE VOTING POWER 0 SHARES BENEFICIALLY 6. SHARED VOTING POWER 296,805 OWNED BY EACH REPORTING 7. SOLE DISPOSITIVE POWER 0 PERSON WITH: 8. SHARED DISPOSITIVE POWER 296,805 9. Aggregate Amount Beneficially Owned by Each Reporting Person 296,805 10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] 11. Percent of Class Represented by Amount in Row (9) 5.2% 12. Type of Reporting Person (See Instructions) IA Page 4 of 13 Pages CUSIP No. 090931106 1. Names of Reporting Persons I.R.S. Identification Nos. of above persons (entities only) Apis Capital, LP 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) [ ] (b) [X] 3. SEC Use Only 4. Citizenship or Place of Organization Delaware NUMBER OF 5. SOLE VOTING POWER 0 SHARES BENEFICIALLY 6. SHARED VOTING POWER 13,790 OWNED BY EACH REPORTING 7. SOLE DISPOSITIVE POWER 0 PERSON WITH: 8. SHARED DISPOSITIVE POWER 13,790 9. Aggregate Amount Beneficially Owned by Each Reporting Person 13,790 10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] 11. Percent of Class Represented by Amount in Row (9) 0.2% 12. Type of Reporting Person (See Instructions) PN Page 5 of 13 Pages CUSIP No. 090931106 1. Names of Reporting Persons I.R.S. Identification Nos. of above persons (entities only) Apis Capital (QP), LP 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) [ ] (b) [X] 3. SEC Use Only 4. Citizenship or Place of Organization Delaware NUMBER OF 5. SOLE VOTING POWER 0 SHARES BENEFICIALLY 6. SHARED VOTING POWER 18,220 OWNED BY EACH REPORTING 7. SOLE DISPOSITIVE POWER 0 PERSON WITH: 8. SHARED DISPOSITIVE POWER 18,220 9. Aggregate Amount Beneficially Owned by Each Reporting Person 18,220 10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] 11. Percent of Class Represented by Amount in Row (9) 0.3% 12. Type of Reporting Person (See Instructions) PN Page 6 of 13 Pages CUSIP No. 090931106 1. Names of Reporting Persons I.R.S. Identification Nos. of above persons (entities only) Apis Offshore Capital, Ltd. 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) [ ] (b) [X] 3. SEC Use Only 4. Citizenship or Place of Organization Cayman Islands NUMBER OF 5. SOLE VOTING POWER 0 SHARES BENEFICIALLY 6. SHARED VOTING POWER 81,870 OWNED BY EACH REPORTING 7. SOLE DISPOSITIVE POWER 0 PERSON WITH: 8. SHARED DISPOSITIVE POWER 81,870 9. Aggregate Amount Beneficially Owned by Each Reporting Person 81,870 10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] 11. Percent of Class Represented by Amount in Row (9) 1.4% 12. Type of Reporting Person (See Instructions) CO Page 7 of 13 Pages CUSIP No. 090931106 1. Names of Reporting Persons I.R.S. Identification Nos. of above persons (entities only) Apis Global Deep Value, LP 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) [ ] (b) [X] 3. SEC Use Only 4. Citizenship or Place of Organization Delaware NUMBER OF 5. SOLE VOTING POWER 0 SHARES BENEFICIALLY 6. SHARED VOTING POWER 60,944 OWNED BY EACH REPORTING 7. SOLE DISPOSITIVE POWER 0 PERSON WITH: 8. SHARED DISPOSITIVE POWER 60,944 9. Aggregate Amount Beneficially Owned by Each Reporting Person 60,944 10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] 11. Percent of Class Represented by Amount in Row (9) 1.1% 12. Type of Reporting Person (See Instructions) PN Page 8 of 13 Pages CUSIP No. 090931106 1. Names of Reporting Persons I.R.S. Identification Nos. of above persons (entities only) Apis Global Deep Value Offshore, Ltd. 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) [ ] (b) [X] 3. SEC Use Only 4. Citizenship or Place of Organization Cayman Islands NUMBER OF 5. SOLE VOTING POWER 0 SHARES BENEFICIALLY 6. SHARED VOTING POWER 121,981 OWNED BY EACH REPORTING 7. SOLE DISPOSITIVE POWER 0 PERSON WITH: 8. SHARED DISPOSITIVE POWER 121,981 9. Aggregate Amount Beneficially Owned by Each Reporting Person 121,981 10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] 11. Percent of Class Represented by Amount in Row (9) 2.1% 12. Type of Reporting Person (See Instructions) CO Page 9 of 13 Pages EXPLANATORY NOTE Item 1. (a) The name of the issuer is BioSpecifics Technologies Corp. (the "Issuer"). (b) The principal executive offices of the Issuer are located at 35 Wilbur Street, Lynbrook, NY 11563. Item 2. (a) This Statement on Schedule 13G (this "Statement") is being filed by (i) Apis Capital, LP, a Delaware limited partnership ("Apis Capital"), (ii) Apis Capital (QP), LP, a Delaware limited partnership ("Apis QP"), (iii) Apis Capital Offshore, Ltd., a Cayman Islands exempted company ("Apis Offshore"), (iv) Apis Global Deep Value, LP, a Delaware limited partnership ("Apis Deep Value"), (v) Apis Global Deep Value Offshore, Ltd., a Cayman Islands exempted company ("Apis Deep Value Offshore", and together with Apis Capital, Apis QP, Apis Offshore and Apis Deep Value, the "Funds"), (vi) Apis Capital Advisors, LLC, a Delaware limited liability company (the "Investment Manager"), which serves as the general partner and/or investment manager of the Funds, (vii) Steven A. Werber, Jr. and (viii) Daniel J. Barker (all of the foregoing, collectively, the "Filers"). Each Fund is a private investment vehicle formed for the purpose of investing and trading in a wide variety of securities and financial instruments. Messrs. Werber and Barker are the Managing Members of the Investment Manager and the Portfolio Managers for the Funds. The Funds directly own all of the respective shares reported in this Statement. Messrs. Werber and Barker and the Investment Manager may be deemed to share with the Funds voting and dispositive power with respect to such shares. Each Filer disclaims beneficial ownership with respect to any shares other than those owned directly by such Filer. (b) The principal business office of Messrs. Werber and Barker, Apis Capital, Apis QP, Apis Deep Value and the Investment Manager is: 53 Forest Avenue, Suite 103 Old Greenwich, Connecticut 06870 USA The principal business office of Apis Offshore and Apis Deep Value Offshore is: c/o dms Corporate Services Ltd. Ansbacher House 20 Genesis Close, George Town PO Box 1344 Grand Cayman KY1-1108 Cayman Islands Page 10 of 13 Pages (c) For citizenship information see Item 4 of the cover page of each Filer. (d) This Statement relates to the Common Stock, $0.001 par value, of the Issuer (the "Common Stock"). (e) The CUSIP Number of the Common Stock is listed on the cover pages hereto. Item 3. If this statement is filed pursuant to 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: (a) [ ] Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o). (b) [ ] Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c). (c) [ ] Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c). (d) [ ] Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8). (e) [ ] An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E); (f) [ ] An employee benefit plan or endowment fund in accordance with 240.13d-1(b)(1)(ii)(F); (g) [ ] A parent holding company or control person in accordance with 240.13d-1(b)(1)(ii)(G); (h) [ ] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) [ ] A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) [ ] Group, in accordance with 240.13d-1(b)(1)(ii)(J). Not applicable. Item 4. Ownership. See Items 5-9 and 11 on the cover page for each Filer, and Item 2, which information is given as of March 17, 2008, and is based on 5,700,000 shares of Common Stock outstanding as of March 19, 2008, as reported directly from the Issuer. Item 5. Ownership of Five Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following: [ ] Not applicable. Page 11 of 13 Pages Item 6. Ownership of More than Five Percent on Behalf of Another Person. Not applicable. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. Not applicable. Item 8. Identification and Classification of Members of the Group. Not applicable. Item 9. Notice of Dissolution of Group. Not applicable. Item 10. Certification. (a) Not applicable. (b) By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. Page 12 of 13 Pages SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: March 25, 2008 DANIEL J. BARKER APIS CAPITAL ADVISORS, LLC APIS CAPITAL, LP APIS CAPITAL (QP), LP APIS CAPITAL OFFSHORE, LTD. APIS GLOBAL DEEP VALUE, LP APIS GLOBAL DEEP VALUE OFFSHORE, LTD. By: /s/ Daniel J. Barker ------------------------------------- Daniel J. Barker, for himself, as Managing Member of the Investment Manager and as Portfolio Manager of each of the Funds /s/ Steven A. Werber, Jr. ----------------------------------------- Steven A. Werber, Jr. Page 13 of 13 Pages EXHIBIT INDEX Exhibit No. Document 1 Joint Filing Agreement Exhibit 1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the Common Stock, $0.001 par value, of BioSpecifics Technologies Corp., and further agree that this Joint Filing Agreement be included as an Exhibit to such joint filing. In evidence thereof, the undersigned hereby execute this Agreement. Dated: March 25, 2008 DANIEL J. BARKER APIS CAPITAL ADVISORS, LLC APIS CAPITAL, LP APIS CAPITAL (QP), LP APIS CAPITAL OFFSHORE, LTD. APIS GLOBAL DEEP VALUE, LP APIS GLOBAL DEEP VALUE OFFSHORE, LTD. By: /s/ Daniel J. Barker ------------------------------------- Daniel J. Barker, for himself, as Managing Member of the Investment Manager and as Portfolio Manager of each of the Funds /s/ Steven A. Werber, Jr. ----------------------------------------- Steven A. Werber, Jr. -----END PRIVACY-ENHANCED MESSAGE-----